143 related articles for article (PubMed ID: 21953129)
21. Neck circumference correlates with tumor size and lateral lymph node metastasis in men with small papillary thyroid carcinoma.
Kim MR; Kim SS; Huh JE; Lee BJ; Lee JC; Jeon YK; Kim BH; Kim SJ; Wang SG; Kim YK; Kim IJ
Korean J Intern Med; 2013 Jan; 28(1):62-71. PubMed ID: 23345998
[TBL] [Abstract][Full Text] [Related]
22. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
23. Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study.
Shah PK; Shah KK; Karakousis GC; Reinke CE; Kelz RR; Fraker DL
Ann Surg Oncol; 2012 May; 19(5):1453-9. PubMed ID: 21913023
[TBL] [Abstract][Full Text] [Related]
24. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
25. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
26. The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.
Rajeev P; Ahmed S; Ezzat TM; Sadler GP; Mihai R
Langenbecks Arch Surg; 2013 Mar; 398(3):377-82. PubMed ID: 23274361
[TBL] [Abstract][Full Text] [Related]
27. Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
Dong W; Horiuchi K; Tokumitsu H; Sakamoto A; Noguchi E; Ueda Y; Okamoto T
Thyroid; 2019 Jun; 29(6):802-808. PubMed ID: 30931815
[No Abstract] [Full Text] [Related]
28. Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma.
Moritani S
Thyroid; 2014 Dec; 24(12):1779-83. PubMed ID: 25157399
[TBL] [Abstract][Full Text] [Related]
29. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
31. Lateral neck recurrence from papillary thyroid carcinoma: Predictive factors and prognostic significance.
Giordano D; Frasoldati A; Kasperbauer JL; Gabrielli E; Pernice C; Zini M; Pedroni C; Cavuto S; Barbieri V
Laryngoscope; 2015 Sep; 125(9):2226-31. PubMed ID: 25510637
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival.
Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2006 May; 30(5):780-6. PubMed ID: 16411013
[TBL] [Abstract][Full Text] [Related]
33. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
34. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
35. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
[No Abstract] [Full Text] [Related]
36. Analysis of prognostic factors in patients with multiple recurrences of papillary thyroid carcinoma.
Kim KM; Park JB; Bae KS; Kang SJ
Surg Oncol; 2012 Sep; 21(3):185-90. PubMed ID: 21855321
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
38. Older Age Significantly Affects Mortality of Patients with Papillary Thyroid Carcinoma Only When They Have High-Risk Features.
Ito Y; Miyauchi A; Higashiyama T; Masuoka H; Kihara M; Miya A
World J Surg; 2020 Jun; 44(6):1885-1891. PubMed ID: 32095856
[TBL] [Abstract][Full Text] [Related]
39. A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study.
Lee JH; Chung YS; Lee YD
Head Neck; 2017 Apr; 39(4):767-771. PubMed ID: 28139038
[TBL] [Abstract][Full Text] [Related]
40. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
